-
1
-
-
6044239439
-
The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2′-deoxycytidine
-
Alleman WG, Tabios RL, Chandramouli GV, Aprelikova ON, Torres-Cabala C, Mendoza A, Rogers C, Sopko NA, Linehan WM, Vasselli JR. 2004. The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2′-deoxycytidine. Clin Cancer Res 10:7011-7021.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7011-7021
-
-
Alleman, W.G.1
Tabios, R.L.2
Chandramouli, G.V.3
Aprelikova, O.N.4
Torres-Cabala, C.5
Mendoza, A.6
Rogers, C.7
Sopko, N.A.8
Linehan, W.M.9
Vasselli, J.R.10
-
2
-
-
3542998048
-
Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells
-
Ammanamanchi S, Brattain MG. 2004. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells. J Biol Chem 279:32620-32625.
-
(2004)
J Biol Chem
, vol.279
, pp. 32620-32625
-
-
Ammanamanchi, S.1
Brattain, M.G.2
-
3
-
-
0032568956
-
Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2′-deoxycytidine
-
Ammanamanchi S, Kim SJ, Sun LZ, Brattain MG. 1998. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2′-deoxycytidine. J Biol Chem 273:16527-16534.
-
(1998)
J Biol Chem
, vol.273
, pp. 16527-16534
-
-
Ammanamanchi, S.1
Kim, S.J.2
Sun, L.Z.3
Brattain, M.G.4
-
4
-
-
0344990164
-
Phase 1 trial of continuous infusion 5-aza-2′-deoxycytidine
-
Aparicio A, Eads CA, Leong LA, Laird PW, Newman EM, Synold TW, Baker SD, Zhao M, Weber JS. 2003. Phase 1 trial of continuous infusion 5-aza-2′-deoxycytidine. Cancer Chemother Pharmacol 51:231-239.
-
(2003)
Cancer Chemother Pharmacol
, vol.51
, pp. 231-239
-
-
Aparicio, A.1
Eads, C.A.2
Leong, L.A.3
Laird, P.W.4
Newman, E.M.5
Synold, T.W.6
Baker, S.D.7
Zhao, M.8
Weber, J.S.9
-
5
-
-
33645210836
-
Hydralazine target: From blood vessels to the epigenome
-
Arce C, Segura-Pacheco B, Perez-Cardenas E, Taja-Chayeb L, Candelaria M, Duennas-Gonzalez A. 2006. Hydralazine target: from blood vessels to the epigenome. J Transl Med 4:10.
-
(2006)
J Transl Med
, vol.4
, pp. 10
-
-
Arce, C.1
Segura-Pacheco, B.2
Perez-Cardenas, E.3
Taja-Chayeb, L.4
Candelaria, M.5
Duennas-Gonzalez, A.6
-
6
-
-
0035798454
-
Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas
-
Arnold JM, Cummings M, Purdie D, Chenevix-Trench G. 2001. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer 85:1351-1358.
-
(2001)
Br J Cancer
, vol.85
, pp. 1351-1358
-
-
Arnold, J.M.1
Cummings, M.2
Purdie, D.3
Chenevix-Trench, G.4
-
7
-
-
29244453281
-
Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis
-
Auerkari EI. 2006. Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis. Oral Oncol 42:5-13.
-
(2006)
Oral Oncol
, vol.42
, pp. 5-13
-
-
Auerkari, E.I.1
-
8
-
-
0033558192
-
Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers
-
Bachman KE, Herman JG, Corn PG, Merlo A, Costello JF, Cavenee WK, Baylin SB, Graff JR. 1999. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res 59:798-802.
-
(1999)
Cancer Res
, vol.59
, pp. 798-802
-
-
Bachman, K.E.1
Herman, J.G.2
Corn, P.G.3
Merlo, A.4
Costello, J.F.5
Cavenee, W.K.6
Baylin, S.B.7
Graff, J.R.8
-
9
-
-
0037124164
-
6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers
-
6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers. Br J Cancer 86:1888-1892.
-
(2002)
Br J Cancer
, vol.86
, pp. 1888-1892
-
-
Bae, S.I.1
Lee, H.S.2
Kim, S.H.3
Kim, W.H.4
-
10
-
-
31344466008
-
DNA methylation and gene silencing in cancer
-
Baylin SB. 2005. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2:S4-11-S4-11.
-
(2005)
Nat Clin Pract Oncol
, vol.2
-
-
Baylin, S.B.1
-
11
-
-
0032578509
-
Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
-
Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG. 1998. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95:11891-11896.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 11891-11896
-
-
Belinsky, S.A.1
Nikula, K.J.2
Palmisano, W.A.3
Michels, R.4
Saccomanno, G.5
Gabrielson, E.6
Baylin, S.B.7
Herman, J.G.8
-
12
-
-
0031964055
-
Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines
-
Bender CM, Pao MM, Jones PA. 1998. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 58:95-101.
-
(1998)
Cancer Res
, vol.58
, pp. 95-101
-
-
Bender, C.M.1
Pao, M.M.2
Jones, P.A.3
-
13
-
-
0034917318
-
Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells
-
Bovenzi V, Momparler RL. 2001. Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. Cancer Chemother Pharmacol 48:71-76.
-
(2001)
Cancer Chemother Pharmacol
, vol.48
, pp. 71-76
-
-
Bovenzi, V.1
Momparler, R.L.2
-
14
-
-
22244435605
-
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
-
Brueckner B, Boy RG, Siedlecki P, Musch T, Kliem HC, Zielenkiewicz P, Suhai S, Wiessler M, Lyko F. 2005. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res 65:6305-6311.
-
(2005)
Cancer Res
, vol.65
, pp. 6305-6311
-
-
Brueckner, B.1
Boy, R.G.2
Siedlecki, P.3
Musch, T.4
Kliem, H.C.5
Zielenkiewicz, P.6
Suhai, S.7
Wiessler, M.8
Lyko, F.9
-
15
-
-
0034905872
-
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase
-
Butler LM, Webb Y, Agus DB, Higgins B, Tolentino TR, Kutko MC, LaQuaglia MP, Drobnjak M, Cordon-Cardo C, Scher HI, Breslow R, Richon VM, Rifkind RA, Marks PA. 2001. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin Cancer Res 7:962-970.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 962-970
-
-
Butler, L.M.1
Webb, Y.2
Agus, D.B.3
Higgins, B.4
Tolentino, T.R.5
Kutko, M.C.6
LaQuaglia, M.P.7
Drobnjak, M.8
Cordon-Cardo, C.9
Scher, H.I.10
Breslow, R.11
Richon, V.M.12
Rifkind, R.A.13
Marks, P.A.14
-
16
-
-
0242442595
-
Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas
-
Byun DS, Cho K, Ryu BK, Lee MG, Kang MJ, Kim HR, Chi SG. 2003. Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Res 63:7068-7075.
-
(2003)
Cancer Res
, vol.63
, pp. 7068-7075
-
-
Byun, D.S.1
Cho, K.2
Ryu, B.K.3
Lee, M.G.4
Kang, M.J.5
Kim, H.R.6
Chi, S.G.7
-
17
-
-
11144290778
-
Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: Immunotherapeutic implications
-
Calabro L, Fonsatti E, Altomonte M, Pezzani L, Colizzi F, Nanni P, Gattei V, Sigalotti L, Maio M. 2005. Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implications. J Cell Physiol 202:474-477.
-
(2005)
J Cell Physiol
, vol.202
, pp. 474-477
-
-
Calabro, L.1
Fonsatti, E.2
Altomonte, M.3
Pezzani, L.4
Colizzi, F.5
Nanni, P.6
Gattei, V.7
Sigalotti, L.8
Maio, M.9
-
18
-
-
0032948005
-
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
-
Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. 1999. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21:103-107.
-
(1999)
Nat Genet
, vol.21
, pp. 103-107
-
-
Cameron, E.E.1
Bachman, K.E.2
Myohanen, S.3
Herman, J.G.4
Baylin, S.B.5
-
19
-
-
4644259264
-
Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation
-
Camphausen K, Scott T, Sproull M, Tofilon PJ. 2004. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation. Clin Cancer Res 10:6066-6071.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6066-6071
-
-
Camphausen, K.1
Scott, T.2
Sproull, M.3
Tofilon, P.J.4
-
20
-
-
0017886958
-
Sodium butyrate inhibits histone deacetylation in cultured cells
-
Candido EP, Reeves R, Davie JR. 1978. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14:105-113.
-
(1978)
Cell
, vol.14
, pp. 105-113
-
-
Candido, E.P.1
Reeves, R.2
Davie, J.R.3
-
21
-
-
0036098559
-
CpG island methylation in aberrant crypt foci of the colorectum
-
Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR. Rashid A. 2002. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 160:1823-1830.
-
(2002)
Am J Pathol
, vol.160
, pp. 1823-1830
-
-
Chan, A.O.1
Broaddus, R.R.2
Houlihan, P.S.3
Issa, J.P.4
Hamilton, S.R.5
Rashid, A.6
-
22
-
-
26444561533
-
Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family
-
Chen ZX, Mann JR, Hsieh CL, Riggs AD, Chedin F. 2005. Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem 95:902-917.
-
(2005)
J Cell Biochem
, vol.95
, pp. 902-917
-
-
Chen, Z.X.1
Mann, J.R.2
Hsieh, C.L.3
Riggs, A.D.4
Chedin, F.5
-
23
-
-
0037420191
-
Inhibition of DNA methylation and reactivation of silenced genes by zebularine
-
Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, Marquez VE, Jones PA, Selker EU. 2003. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst 95:399-409.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 399-409
-
-
Cheng, J.C.1
Matsen, C.B.2
Gonzales, F.A.3
Ye, W.4
Greer, S.5
Marquez, V.E.6
Jones, P.A.7
Selker, E.U.8
-
24
-
-
14844307097
-
Epigenetic regulation by histone methylation and histone variants
-
Cheung P, Lau P. 2005. Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol 19:563-573.
-
(2005)
Mol Endocrinol
, vol.19
, pp. 563-573
-
-
Cheung, P.1
Lau, P.2
-
25
-
-
0036035211
-
Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression
-
Chicoine E, Esteve PO, Robledo O, Van TC, Potworowski EF, St-Pierre Y. 2002. Evidence for the role of promoter methylation in the regulation of MMP-9 gene expression. Biochem Biophys Res Commun 297:765-772.
-
(2002)
Biochem Biophys Res Commun
, vol.297
, pp. 765-772
-
-
Chicoine, E.1
Esteve, P.O.2
Robledo, O.3
Van, T.C.4
Potworowski, E.F.5
St-Pierre, Y.6
-
26
-
-
0032920527
-
Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2′-deoxycytidine (5-AZA-CdR)
-
Coral S, Sigalotti L, Gasparollo A, Cattarossi I, Visintin A, Cattelan A, Altomonte M, Maio M. 1999. Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2′-deoxycytidine (5-AZA-CdR). J Immunother 22:16-24.
-
(1999)
J Immunother
, vol.22
, pp. 16-24
-
-
Coral, S.1
Sigalotti, L.2
Gasparollo, A.3
Cattarossi, I.4
Visintin, A.5
Cattelan, A.6
Altomonte, M.7
Maio, M.8
-
27
-
-
0036023437
-
5-aza-2′-deoxycytidine- induced expression of functional cancer testis antigens in human renal cell carcinoma: Immunotherapeutic implications
-
Coral S, Sigalotti L, Altomonte M, Engelsberg A, Colizzi F, Cattarossi I, Maraskovsky E, Jager E, Seliger B, Maio M. 2002. 5-aza-2′-deoxycytidine- induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications. Clin Cancer Res 8:2690-2695.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2690-2695
-
-
Coral, S.1
Sigalotti, L.2
Altomonte, M.3
Engelsberg, A.4
Colizzi, F.5
Cattarossi, I.6
Maraskovsky, E.7
Jager, E.8
Seliger, B.9
Maio, M.10
-
28
-
-
33644879237
-
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications
-
Coral S, Sigalotti L, Colizzi F, Spessotto A, Nardi G, Cortini E, Pezzani L, Fratta E, Fonsatti E, Di Giacomo AM, Nicotra MR, Natali PG, Altomonte M, Maio M. 2006. Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: immunotherapeutic implications. J Cell Physiol 207:58-66.
-
(2006)
J Cell Physiol
, vol.207
, pp. 58-66
-
-
Coral, S.1
Sigalotti, L.2
Colizzi, F.3
Spessotto, A.4
Nardi, G.5
Cortini, E.6
Pezzani, L.7
Fratta, E.8
Fonsatti, E.9
Di Giacomo, A.M.10
Nicotra, M.R.11
Natali, P.G.12
Altomonte, M.13
Maio, M.14
-
29
-
-
0033565514
-
Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation
-
Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, Herman JG. 1999. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 59:3352-3356.
-
(1999)
Cancer Res
, vol.59
, pp. 3352-3356
-
-
Corn, P.G.1
Kuerbitz, S.J.2
van Noesel, M.M.3
Esteller, M.4
Compitello, N.5
Baylin, S.B.6
Herman, J.G.7
-
30
-
-
0033740401
-
E-cadherin expression is silenced by 5′ CpG island methylation in acute leukemia
-
Corn PG, Smith BD, Ruckdeschel ES, Douglas D, Baylin SB, Herman JG. 2000. E-cadherin expression is silenced by 5′ CpG island methylation in acute leukemia. Clin Cancer Res 6:4243-4248.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 4243-4248
-
-
Corn, P.G.1
Smith, B.D.2
Ruckdeschel, E.S.3
Douglas, D.4
Baylin, S.B.5
Herman, J.G.6
-
31
-
-
0031731906
-
Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells
-
Cote S, Sinnett D, Momparler RL. 1998. Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs 9:743-750.
-
(1998)
Anticancer Drugs
, vol.9
, pp. 743-750
-
-
Cote, S.1
Sinnett, D.2
Momparler, R.L.3
-
32
-
-
0033918563
-
Epigeneticinactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
-
Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. 2000. Epigeneticinactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25:315-319.
-
(2000)
Nat Genet
, vol.25
, pp. 315-319
-
-
Dammann, R.1
Li, C.2
Yoon, J.H.3
Chin, P.L.4
Bates, S.5
Pfeifer, G.P.6
-
33
-
-
13944267211
-
6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins
-
6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins. Mol Cancer Ther 4:61-69.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 61-69
-
-
Danam, R.P.1
Howell, S.R.2
Brent, T.P.3
Harris, L.C.4
-
34
-
-
33646419009
-
Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer
-
Deng G, Nguyen A, Tanaka H, Matsuzaki K, Bell I, Mehta KR, Terdiman JP, Waldman FM, Kakar S, Gum J, Crawley S, Sleisenger MH, Kim YS. 2006. Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. Int J Cancer 118:2999-3005.
-
(2006)
Int J Cancer
, vol.118
, pp. 2999-3005
-
-
Deng, G.1
Nguyen, A.2
Tanaka, H.3
Matsuzaki, K.4
Bell, I.5
Mehta, K.R.6
Terdiman, J.P.7
Waldman, F.M.8
Kakar, S.9
Gum, J.10
Crawley, S.11
Sleisenger, M.H.12
Kim, Y.S.13
-
35
-
-
0029957792
-
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
-
De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. 1996. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93:7149-7153.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 7149-7153
-
-
De Smet, C.1
De Backer, O.2
Faraoni, I.3
Lurquin, C.4
Brasseur, F.5
Boon, T.6
-
36
-
-
0032694084
-
DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter
-
De Smet C, Lurquin C, Lethe B, Martelange V, Boon T. 1999. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19:7327-7335.
-
(1999)
Mol Cell Biol
, vol.19
, pp. 7327-7335
-
-
De Smet, C.1
Lurquin, C.2
Lethe, B.3
Martelange, V.4
Boon, T.5
-
37
-
-
0030843274
-
Methylation of the BRCA1 gene in sporadic breast cancer
-
Dobrovic A, Simpfendorfer D. 1997. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57:3347-3350.
-
(1997)
Cancer Res
, vol.57
, pp. 3347-3350
-
-
Dobrovic, A.1
Simpfendorfer, D.2
-
38
-
-
29244477848
-
Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction
-
Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, Ricci-Vitiani L, Signore M, Stassi G, Larocca LM, Crino L, Peschle C, De Maria R. 2005. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction. Cancer Res 65:11469-11477.
-
(2005)
Cancer Res
, vol.65
, pp. 11469-11477
-
-
Eramo, A.1
Pallini, R.2
Lotti, F.3
Sette, G.4
Patti, M.5
Bartucci, M.6
Ricci-Vitiani, L.7
Signore, M.8
Stassi, G.9
Larocca, L.M.10
Crino, L.11
Peschle, C.12
De Maria, R.13
-
39
-
-
0033680062
-
Epigenetic lesions causing genetic lesions in human cancer: Promoter hypermethylation of DNA repair genes
-
Esteller M. 2000. Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 36:2294-2300.
-
(2000)
Eur J Cancer
, vol.36
, pp. 2294-2300
-
-
Esteller, M.1
-
40
-
-
0942279488
-
6-methylguanine DNA methyltransferase in human cancer
-
6-methylguanine DNA methyltransferase in human cancer. Oncogene 23:1-8.
-
(2004)
Oncogene
, vol.23
, pp. 1-8
-
-
Esteller, M.1
Herman, J.G.2
-
41
-
-
0032487831
-
MLHI promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas
-
Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. 1998. MLHI promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 17:2413-2417.
-
(1998)
Oncogene
, vol.17
, pp. 2413-2417
-
-
Esteller, M.1
Levine, R.2
Baylin, S.B.3
Ellenson, L.H.4
Herman, J.G.5
-
43
-
-
0034607234
-
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
-
Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG. 2000a. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564-569.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 564-569
-
-
Esteller, M.1
Silva, J.M.2
Dominguez, G.3
Bonilla, F.4
Matias-Guiu, X.5
Lerma, E.6
Bussaglia, E.7
Prat, J.8
Harkes, I.C.9
Repasky, E.A.10
Gabrielson, E.11
Schutte, M.12
Baylin, S.B.13
Herman, J.G.14
-
44
-
-
0034662626
-
Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer
-
Esteller M, Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG. 2000b. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60:4366-4371.
-
(2000)
Cancer Res
, vol.60
, pp. 4366-4371
-
-
Esteller, M.1
Sparks, A.2
Toyota, M.3
Sanchez-Cespedes, M.4
Capella, G.5
Peinado, M.A.6
Gonzalez, S.7
Tarafa, G.8
Sidransky, D.9
Meltzer, S.J.10
Baylin, S.B.11
Herman, J.G.12
-
45
-
-
0035297539
-
p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of M DM2
-
Esteller M, Cordon-Cardo C, Corn PG, Meltzer SJ, Pohar KS, Watkins DN, Capella G, Peinado MA, Matias-Guiu X, Prat J, Baylin SB, Herman JG. 2001. p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of M DM2. Cancer Res 61:2816-2821.
-
(2001)
Cancer Res
, vol.61
, pp. 2816-2821
-
-
Esteller, M.1
Cordon-Cardo, C.2
Corn, P.G.3
Meltzer, S.J.4
Pohar, K.S.5
Watkins, D.N.6
Capella, G.7
Peinado, M.A.8
Matias-Guiu, X.9
Prat, J.10
Baylin, S.B.11
Herman, J.G.12
-
46
-
-
0037108867
-
Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer
-
Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB, Herman JG. 2002. Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer. Cancer Res 62:5902-5905.
-
(2002)
Cancer Res
, vol.62
, pp. 5902-5905
-
-
Esteller, M.1
Guo, M.2
Moreno, V.3
Peinado, M.A.4
Capella, G.5
Galm, O.6
Baylin, S.B.7
Herman, J.G.8
-
47
-
-
0345275879
-
Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines
-
Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. 2003. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63:7563-7570.
-
(2003)
Cancer Res
, vol.63
, pp. 7563-7570
-
-
Fang, M.Z.1
Wang, Y.2
Ai, N.3
Hou, Z.4
Sun, Y.5
Lu, H.6
Welsh, W.7
Yang, C.S.8
-
48
-
-
1042278765
-
The history of cancer epigenetics
-
Feinberg AP, Tycko B. 2004. The history of cancer epigenetics. Nat Rev Cancer 4:143-153.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 143-153
-
-
Feinberg, A.P.1
Tycko, B.2
-
49
-
-
0020699979
-
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
-
Feinberg AP, Vogelstein B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92.
-
(1983)
Nature
, vol.301
, pp. 89-92
-
-
Feinberg, A.P.1
Vogelstein, B.2
-
50
-
-
0036392059
-
DNA methylation and genomic imprinting: Insights from cancer into epigenetic mechanisms
-
Feinberg AP, Cui H, Ohlsson R. 2002. DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin Cancer Biol 12:389-398.
-
(2002)
Semin Cancer Biol
, vol.12
, pp. 389-398
-
-
Feinberg, A.P.1
Cui, H.2
Ohlsson, R.3
-
51
-
-
0029002319
-
Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression
-
Ferguson AT, Lapidus RG, Baylin SB, Davidson NE. 1995. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res 55:2279-2283.
-
(1995)
Cancer Res
, vol.55
, pp. 2279-2283
-
-
Ferguson, A.T.1
Lapidus, R.G.2
Baylin, S.B.3
Davidson, N.E.4
-
52
-
-
0031434813
-
Role of estrogen receptor gene demethylation and DNA methyltransferase. DNA adduct formation in 5-aza-2′deoxycytidine-induced cytotoxicity in human breast cancer cells
-
Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, Muller MT, Davidson NE. 1997. Role of estrogen receptor gene demethylation and DNA methyltransferase. DNA adduct formation in 5-aza-2′deoxycytidine-induced cytotoxicity in human breast cancer cells. J Biol Chem 272:32260-32266.
-
(1997)
J Biol Chem
, vol.272
, pp. 32260-32266
-
-
Ferguson, A.T.1
Vertino, P.M.2
Spitzner, J.R.3
Baylin, S.B.4
Muller, M.T.5
Davidson, N.E.6
-
53
-
-
12944275670
-
High frequency of hypermethylation at the 14-3-3sigma locus leads to gene silencing in breast cancer
-
Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S. 2000. High frequency of hypermethylation at the 14-3-3sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 97:6049-6054.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 6049-6054
-
-
Ferguson, A.T.1
Evron, E.2
Umbricht, C.B.3
Pandita, T.K.4
Chan, T.A.5
Hermeking, H.6
Marks, J.R.7
Lambers, A.R.8
Futreal, P.A.9
Stampfer, M.R.10
Sukumar, S.11
-
54
-
-
20144388146
-
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
-
Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Perez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, Esteller M. 2005. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37:391-400.
-
(2005)
Nat Genet
, vol.37
, pp. 391-400
-
-
Fraga, M.F.1
Ballestar, E.2
Villar-Garea, A.3
Boix-Chornet, M.4
Espada, J.5
Schotta, G.6
Bonaldi, T.7
Haydon, C.8
Ropero, S.9
Petrie, K.10
Iyer, N.G.11
Perez-Rosado, A.12
Calvo, E.13
Lopez, J.A.14
Cano, A.15
Calasanz, M.J.16
Colomer, D.17
Piris, M.A.18
Ahn, N.19
Imhof, A.20
Caldas, C.21
Jenuwein, T.22
Esteller, M.23
more..
-
55
-
-
0035855626
-
Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer
-
Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B, Debatin KM. 2001. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20:5865-5877.
-
(2001)
Oncogene
, vol.20
, pp. 5865-5877
-
-
Fulda, S.1
Kufer, M.U.2
Meyer, E.3
van Valen, F.4
Dockhorn-Dworniczak, B.5
Debatin, K.M.6
-
56
-
-
21344462364
-
Methylation silencing of the Apaf-I gene in acute leukemia
-
Furukawa Y, Sutheesophon K, Wada T, Nishimura M, Saito Y, Ishii H, Furukawa Y. 2005. Methylation silencing of the Apaf-I gene in acute leukemia. Mol Cancer Res 3:325-334.
-
(2005)
Mol Cancer Res
, vol.3
, pp. 325-334
-
-
Furukawa, Y.1
Sutheesophon, K.2
Wada, T.3
Nishimura, M.4
Saito, Y.5
Ishii, H.6
Furukawa, Y.7
-
57
-
-
0037358032
-
Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells
-
Gagnon J, Shaker S, Primeau M, Hurtubise A, Momparler RL. 2003. Interaction of 5-aza-2′-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells. Anticancer Drugs 14:193-202.
-
(2003)
Anticancer Drugs
, vol.14
, pp. 193-202
-
-
Gagnon, J.1
Shaker, S.2
Primeau, M.3
Hurtubise, A.4
Momparler, R.L.5
-
58
-
-
0038784365
-
SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma
-
Galm O, Yoshikawa H, Esteller M, Osieka R, Herman JG. 2003. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101:2784-2788.
-
(2003)
Blood
, vol.101
, pp. 2784-2788
-
-
Galm, O.1
Yoshikawa, H.2
Esteller, M.3
Osieka, R.4
Herman, J.G.5
-
59
-
-
23044495284
-
Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies
-
Galm O, Suzuki H, Akiyama Y, Esteller M, Brock MV, Osieka R, Baylin SB, Herman JG. 2005. Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies. Oncogene 24:4799-4805.
-
(2005)
Oncogene
, vol.24
, pp. 4799-4805
-
-
Galm, O.1
Suzuki, H.2
Akiyama, Y.3
Esteller, M.4
Brock, M.V.5
Osieka, R.6
Baylin, S.B.7
Herman, J.G.8
-
60
-
-
0021101229
-
The 5-methylcytosine content of DNA from human tumors
-
Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, Gehrke CW, Ehrlich M. 1983. The 5-methylcytosine content of DNA from human tumors. Nucl Acids Res 11:6883-6894.
-
(1983)
Nucl Acids Res
, vol.11
, pp. 6883-6894
-
-
Gama-Sosa, M.A.1
Slagel, V.A.2
Trewyn, R.W.3
Oxenhandler, R.4
Kuo, K.C.5
Gehrke, C.W.6
Ehrlich, M.7
-
61
-
-
33344456652
-
Histone deacetylase inhibitors: A review of their clinical status as antineoplastic agents
-
Garcia-Manero G, Issa JP. 2005. Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents. Cancer Invest 23:635-642.
-
(2005)
Cancer Invest
, vol.23
, pp. 635-642
-
-
Garcia-Manero, G.1
Issa, J.P.2
-
62
-
-
33750530675
-
Phase 1/2 study of the combination of 5-aza-2′- deoxycytidine with valproic acid in patients with leukemia
-
Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B, Yang H, Rosner G, Verstovsek S, Rytting M, Wierda WG, Ravandi F, Koller C, Xiao L, Faderl S, Estrov Z, Cortes J, O'Brien S, Estey E, Bueso-Ramos C, Fiorentino J, Jabbour E, Issa JP. 2006. Phase 1/2 study of the combination of 5-aza-2′- deoxycytidine with valproic acid in patients with leukemia. Blood 108:3271-3279.
-
(2006)
Blood
, vol.108
, pp. 3271-3279
-
-
Garcia-Manero, G.1
Kantarjian, H.M.2
Sanchez-Gonzalez, B.3
Yang, H.4
Rosner, G.5
Verstovsek, S.6
Rytting, M.7
Wierda, W.G.8
Ravandi, F.9
Koller, C.10
Xiao, L.11
Faderl, S.12
Estrov, Z.13
Cortes, J.14
O'Brien, S.15
Estey, E.16
Bueso-Ramos, C.17
Fiorentino, J.18
Jabbour, E.19
Issa, J.P.20
more..
-
63
-
-
25844432413
-
Epigenetic immunomodulation of hematopoietic malignancies
-
Gattei V, Fonsatti E, Sigalotti L, Degan M, Di Giacomo AM, Altomonte M, Calabro L, Maio M. 2005. Epigenetic immunomodulation of hematopoietic malignancies. Semin Oncol 32:503-510.
-
(2005)
Semin Oncol
, vol.32
, pp. 503-510
-
-
Gattei, V.1
Fonsatti, E.2
Sigalotti, L.3
Degan, M.4
Di Giacomo, A.M.5
Altomonte, M.6
Calabro, L.7
Maio, M.8
-
64
-
-
33644858329
-
Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A
-
Gialitakis M, Kretsovali A, Spilianakis C, Kravariti L, Mages J, Hoffmann R, Hatzopoulos AK, Papamatheakis J. 2006. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. Nucl Acids Res 34:765-772.
-
(2006)
Nucl Acids Res
, vol.34
, pp. 765-772
-
-
Gialitakis, M.1
Kretsovali, A.2
Spilianakis, C.3
Kravariti, L.4
Mages, J.5
Hoffmann, R.6
Hatzopoulos, A.K.7
Papamatheakis, J.8
-
65
-
-
0036861629
-
DNA methyltransferase inhibitors-state of the art
-
Goffin J, Eisenhauer E. 2002. DNA methyltransferase inhibitors-state of the art. Ann Oncol 13:1699-1716.
-
(2002)
Ann Oncol
, vol.13
, pp. 1699-1716
-
-
Goffin, J.1
Eisenhauer, E.2
-
66
-
-
33748046812
-
Phase I trial of sequential low-dose 5-aza-2′-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma
-
Gollob JA, Sciambi CJ, Peterson BL, Richmond T, Thoreson M, Moran K, Dressman HK, Jelinek J, Issa JP. 2006. Phase I trial of sequential low-dose 5-aza-2′-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. Clin Cancer Res 12:4619-4627.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 4619-4627
-
-
Gollob, J.A.1
Sciambi, C.J.2
Peterson, B.L.3
Richmond, T.4
Thoreson, M.5
Moran, K.6
Dressman, H.K.7
Jelinek, J.8
Issa, J.P.9
-
67
-
-
0028849277
-
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
-
Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE, Baylin SB. 1995. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195-5199.
-
(1995)
Cancer Res
, vol.55
, pp. 5195-5199
-
-
Graff, J.R.1
Herman, J.G.2
Lapidus, R.G.3
Chopra, H.4
Xu, R.5
Jarrard, D.F.6
Isaacs, W.B.7
Pitha, P.M.8
Davidson, N.E.9
Baylin, S.B.10
-
68
-
-
0842277812
-
Histone deacetylase (HDAC) inhibitor activation of p2IWAFI involves changes in promoter-associated proteins, including HD AC1
-
Gui CY, Ngo L, Xu WS, Richon VM, Marks PA. 2004. Histone deacetylase (HDAC) inhibitor activation of p2IWAFI involves changes in promoter-associated proteins, including HD AC1. Proc Natl Acad Sci USA 101:1241-1246.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 1241-1246
-
-
Gui, C.Y.1
Ngo, L.2
Xu, W.S.3
Richon, V.M.4
Marks, P.A.5
-
69
-
-
31544432509
-
De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model
-
Guo ZS, Hong JA, Irvine KR, Chen GA, Spiess PJ, Liu Y, Zeng G, Wunderlich JR, Nguyen DM, Restifo NP, Schrump DS. 2006. De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Cancer Res 66:1105-1113.
-
(2006)
Cancer Res
, vol.66
, pp. 1105-1113
-
-
Guo, Z.S.1
Hong, J.A.2
Irvine, K.R.3
Chen, G.A.4
Spiess, P.J.5
Liu, Y.6
Zeng, G.7
Wunderlich, J.R.8
Nguyen, D.M.9
Restifo, N.P.10
Schrump, D.S.11
-
70
-
-
0037310198
-
Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma
-
Gupta A, Godwin AK, Vanderveer L, Lu A, Liu J. 2003. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma. Cancer Res 63:664-673.
-
(2003)
Cancer Res
, vol.63
, pp. 664-673
-
-
Gupta, A.1
Godwin, A.K.2
Vanderveer, L.3
Lu, A.4
Liu, J.5
-
71
-
-
18244401685
-
Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma
-
Hanafusa T, Yumoto Y, Nouso K, Nakatsukasa H, Onishi T, Fujikawa T, Taniyama M, Nakamura S, Uemura M, Takuma Y, Yumoto E, Higashi T, Tsuji T. 2002. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett 176:149-158.
-
(2002)
Cancer Lett
, vol.176
, pp. 149-158
-
-
Hanafusa, T.1
Yumoto, Y.2
Nouso, K.3
Nakatsukasa, H.4
Onishi, T.5
Fujikawa, T.6
Taniyama, M.7
Nakamura, S.8
Uemura, M.9
Takuma, Y.10
Yumoto, E.11
Higashi, T.12
Tsuji, T.13
-
72
-
-
0038243168
-
The role of DNA methylation in setting up chromatin structure during development
-
Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H. 2003. The role of DNA methylation in setting up chromatin structure during development. Nat Genet 34:187-192.
-
(2003)
Nat Genet
, vol.34
, pp. 187-192
-
-
Hashimshony, T.1
Zhang, J.2
Keshet, I.3
Bustin, M.4
Cedar, H.5
-
73
-
-
0028072991
-
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
-
Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, GnarraJR, Linehan WM. 1994. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 9700-9704
-
-
Herman, J.G.1
Latif, F.2
Weng, Y.3
Lerman, M.I.4
Zbar, B.5
Liu, S.6
Samid, D.7
Duan, D.S.8
Gnarra, J.R.9
Linehan, W.M.10
-
74
-
-
0030046322
-
Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B
-
Herman JG, Jen J, Merlo A, Baylin SB. 1996. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res 56:722-727.
-
(1996)
Cancer Res
, vol.56
, pp. 722-727
-
-
Herman, J.G.1
Jen, J.2
Merlo, A.3
Baylin, S.B.4
-
75
-
-
13144266670
-
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
-
Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA, Baylin SB. 1998. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 95:6870-6875.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 6870-6875
-
-
Herman, J.G.1
Umar, A.2
Polyak, K.3
Graff, J.R.4
Ahuja, N.5
Issa, J.P.6
Markowitz, S.7
Willson, J.K.8
Hamilton, S.R.9
Kinzler, K.W.10
Kane, M.F.11
Kolodner, R.D.12
Vogelstein, B.13
Kunkel, T.A.14
Baylin, S.B.15
-
76
-
-
9744251005
-
Biochemistry and biology of mammalian DNA methyltransferases
-
Hermann A, Gowher H, Jeltsch A. 2004. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 61:2571-2587.
-
(2004)
Cell Mol Life Sci
, vol.61
, pp. 2571-2587
-
-
Hermann, A.1
Gowher, H.2
Jeltsch, A.3
-
77
-
-
0034662625
-
Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis
-
Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, Gross N. 2000. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 60:4315-4319.
-
(2000)
Cancer Res
, vol.60
, pp. 4315-4319
-
-
Hopkins-Donaldson, S.1
Bodmer, J.L.2
Bourloud, K.B.3
Brognara, C.B.4
Tschopp, J.5
Gross, N.6
-
78
-
-
33746679765
-
Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2′-deoxycytidine (decitabine) on human breast carcinoma cells
-
Hurtubise A, Momparler RL. 2006. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2′-deoxycytidine (decitabine) on human breast carcinoma cells. Cancer Chemother Pharmacol S8:618-625.
-
(2006)
Cancer Chemother Pharmacol S8
, pp. 618-625
-
-
Hurtubise, A.1
Momparler, R.L.2
-
79
-
-
33744932953
-
Identification of novel target genes by an epigenetic reactivation screen of renal cancer
-
Ibanez de Caceies I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P. 2006. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res 66:5021-5028.
-
(2006)
Cancer Res
, vol.66
, pp. 5021-5028
-
-
Ibanez de Caceies, I.1
Dulaimi, E.2
Hoffman, A.M.3
Al-Saleem, T.4
Uzzo, R.G.5
Cairns, P.6
-
80
-
-
10344260184
-
CpG island methylator phenotype in cancer
-
Issa JP. 2004. CpG island methylator phenotype in cancer. Nat Rev Cancer 4:988-993.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 988-993
-
-
Issa, J.P.1
-
81
-
-
31344460650
-
Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: Dose, duration, and patient selection
-
Issa JP. 2005. Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection. Nat Clin Pract Oncol 2:S24-S29.
-
(2005)
Nat Clin Pract Oncol
, vol.2
-
-
Issa, J.P.1
-
82
-
-
10744233452
-
Phase I study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
-
Issa JP, Garcia-Manero G, Giles FJ, Mannari R, Thomas D, Faderl S, Bayar E, Lyons J, Rosenfeld CS, Cortes J, Kantarjian HM. 2004. Phase I study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies. Blood 103:1635-1640.
-
(2004)
Blood
, vol.103
, pp. 1635-1640
-
-
Issa, J.P.1
Garcia-Manero, G.2
Giles, F.J.3
Mannari, R.4
Thomas, D.5
Faderl, S.6
Bayar, E.7
Lyons, J.8
Rosenfeld, C.S.9
Cortes, J.10
Kantarjian, H.M.11
-
83
-
-
1642498263
-
Frequent hypermethylation of 5′ flanking region of TIMP-2 gene in cervical cancer
-
Ivanova T, Vinokurova S, Petrenko A, Eshilev E, Solovyova N, Kisseljov F, Kisseljova N. 2004. Frequent hypermethylation of 5′ flanking region of TIMP-2 gene in cervical cancer. Int J Cancer 108:882-886.
-
(2004)
Int J Cancer
, vol.108
, pp. 882-886
-
-
Ivanova, T.1
Vinokurova, S.2
Petrenko, A.3
Eshilev, E.4
Solovyova, N.5
Kisseljov, F.6
Kisseljova, N.7
-
84
-
-
0032403081
-
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells
-
Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N. 1998. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Res 58:5310-5314.
-
(1998)
Cancer Res
, vol.58
, pp. 5310-5314
-
-
Jarrard, D.F.1
Kinoshita, H.2
Shi, Y.3
Sandefur, C.4
Hoff, D.5
Meisner, L.F.6
Chang, C.7
Herman, J.G.8
Isaacs, W.B.9
Nassif, N.10
-
85
-
-
0041347519
-
Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?
-
Johnstone RW, Licht JD. 2003. Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? Cancer Cell 4:13-18.
-
(2003)
Cancer Cell
, vol.4
, pp. 13-18
-
-
Johnstone, R.W.1
Licht, J.D.2
-
86
-
-
0033931860
-
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours
-
Jungbluth AA, Stockert E, Chen YT, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N. Busam KJ, Old LJ. 2000. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer 83:493-497.
-
(2000)
Br J Cancer
, vol.83
, pp. 493-497
-
-
Jungbluth, A.A.1
Stockert, E.2
Chen, Y.T.3
Kolb, D.4
Iversen, K.5
Coplan, K.6
Williamson, B.7
Altorki, N.8
Busam, K.J.9
Old, L.J.10
-
87
-
-
0028151343
-
Toxicity of 5-aza-2′- deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation
-
Juttermann R, Li E, Jaenisch R. 1994. Toxicity of 5-aza-2′- deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA 91:11797-11801.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 11797-11801
-
-
Juttermann, R.1
Li, E.2
Jaenisch, R.3
-
88
-
-
3042584653
-
Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting
-
Kaneda M, Okano M, Hata K, Sado T, Tsujimoto N, Li E, Sasaki H. 2004. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429:900-903.
-
(2004)
Nature
, vol.429
, pp. 900-903
-
-
Kaneda, M.1
Okano, M.2
Hata, K.3
Sado, T.4
Tsujimoto, N.5
Li, E.6
Sasaki, H.7
-
89
-
-
0037962005
-
Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia
-
Kantarjian HM, O'Brien S, Cortes J, Giles FJ, Faderl S, Issa JP, Garcia-Manero G, Rios MB, Shan J, Andreeff M, Keating M, Talpaz M. 2003. Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia. Cancer 98:522-528.
-
(2003)
Cancer
, vol.98
, pp. 522-528
-
-
Kantarjian, H.M.1
O'Brien, S.2
Cortes, J.3
Giles, F.J.4
Faderl, S.5
Issa, J.P.6
Garcia-Manero, G.7
Rios, M.B.8
Shan, J.9
Andreeff, M.10
Keating, M.11
Talpaz, M.12
-
90
-
-
33646071894
-
Decitabine improves patient outcomes in myelodysplastic syndromes: Results of a phase III randomized study
-
Kantarjian H, Issa JP, Rosenfeld CS. Bennett JM, Albitar M, DiPersio J, Klimek V, Slack J, de CC, Ravandi F, Helmer RIII, Shen L, Nimer SD, Leavitt R, Raza A, Saba H. 2006a. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 106:1794-1803.
-
(2006)
Cancer
, vol.106
, pp. 1794-1803
-
-
Kantarjian, H.1
Issa, J.P.2
Rosenfeld, C.S.3
Bennett, J.M.4
Albitar, M.5
DiPersio, J.6
Klimek, V.7
Slack, J.8
de, C.C.9
Ravandi, F.10
RIII, H.11
Shen, L.12
Nimer, S.D.13
Leavitt, R.14
Raza, A.15
Saba, H.16
-
91
-
-
34347396470
-
-
Blood
-
Kantarjian H, Oki Y, Garcia-Manero G, Huang X, O'Brien S, Cortes J, Faderl S, Bueso-Ramos C, Ravandi F, Estrov Z, Ferrajoli A, Wierda W, Shan J, Davis J, Giles F, Saba HI, Issa JP. 2006b. Results of a randomized study of three schedules of low-dose decitabine in higher risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood
-
(2006)
Results of a randomized study of three schedules of low-dose decitabine in higher risk myelodysplastic syndrome and chronic myelomonocytic leukemia
-
-
Kantarjian, H.1
Oki, Y.2
Garcia-Manero, G.3
Huang, X.4
O'Brien, S.5
Cortes, J.6
Faderl, S.7
Bueso-Ramos, C.8
Ravandi, F.9
Estrov, Z.10
Ferrajoli, A.11
Wierda, W.12
Shan, J.13
Davis, J.14
Giles, F.15
Saba, H.I.16
Issa, J.P.17
-
92
-
-
0035057219
-
Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2′-deoxycytidine
-
Karpf AR, Moore BC, Ririe TO, Jones DA. 2001. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2′-deoxycytidine. Mol Pharmacol 59:751-757.
-
(2001)
Mol Pharmacol
, vol.59
, pp. 751-757
-
-
Karpf, A.R.1
Moore, B.C.2
Ririe, T.O.3
Jones, D.A.4
-
93
-
-
0033564351
-
Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies
-
Katzenellenbogen RA, Baylin SB, Herman JG. 1999. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93:4347-4353.
-
(1999)
Blood
, vol.93
, pp. 4347-4353
-
-
Katzenellenbogen, R.A.1
Baylin, S.B.2
Herman, J.G.3
-
94
-
-
0242610850
-
Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA
-
Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F. 2003. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 63:7291-7300.
-
(2003)
Cancer Res
, vol.63
, pp. 7291-7300
-
-
Kim, M.S.1
Blake, M.2
Baek, J.H.3
Kohlhagen, G.4
Pommier, Y.5
Carrier, F.6
-
95
-
-
33747889966
-
Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma
-
Kim TY, Zhong S, Fields CR, Kim JH, Robertson KD. 2006. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res 66:7490-7501.
-
(2006)
Cancer Res
, vol.66
, pp. 7490-7501
-
-
Kim, T.Y.1
Zhong, S.2
Fields, C.R.3
Kim, J.H.4
Robertson, K.D.5
-
96
-
-
0030757685
-
DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: Possible implications for role as tumor suppressor gene
-
Kissil JL, Feinstein E, Cohen O, Jones PA, Tsai YC, Knowles MA, Eydmann ME, Kimchi A. 1997. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene. Oncogene 15:403-407.
-
(1997)
Oncogene
, vol.15
, pp. 403-407
-
-
Kissil, J.L.1
Feinstein, E.2
Cohen, O.3
Jones, P.A.4
Tsai, Y.C.5
Knowles, M.A.6
Eydmann, M.E.7
Kimchi, A.8
-
97
-
-
20544473454
-
Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: A potential strategy for uveal melanoma
-
Klisovic DD, Klisovic MI, Effron D, Liu S, Marcucci G, Katz SE. 2005. Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma. Melanoma Res 15:147-153.
-
(2005)
Melanoma Res
, vol.15
, pp. 147-153
-
-
Klisovic, D.D.1
Klisovic, M.I.2
Effron, D.3
Liu, S.4
Marcucci, G.5
Katz, S.E.6
-
98
-
-
32344450824
-
Genomic DNA methylation: The mark and its mediators
-
Klose RJ, Bird AP. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31:89-97.
-
(2006)
Trends Biochem Sci
, vol.31
, pp. 89-97
-
-
Klose, R.J.1
Bird, A.P.2
-
99
-
-
0042168731
-
Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells
-
Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ii-Osman F, Kondraganti S, Lakka SS, Rao JS. 2003. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene 22:4509-4516.
-
(2003)
Oncogene
, vol.22
, pp. 4509-4516
-
-
Konduri, S.D.1
Srivenugopal, K.S.2
Yanamandra, N.3
Dinh, D.H.4
Olivero, W.C.5
Gujrati, M.6
Foster, D.C.7
Kisiel, W.8
Ii-Osman, F.9
Kondraganti, S.10
Lakka, S.S.11
Rao, J.S.12
-
100
-
-
0028152397
-
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
-
Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG. 1994. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91:11733-11737.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 11733-11737
-
-
Lee, W.H.1
Morton, R.A.2
Epstein, J.I.3
Brooks, J.D.4
Campbell, P.A.5
Bova, G.S.6
Hsieh, W.S.7
Isaacs, W.B.8
Nelson, W.G.9
-
101
-
-
3042679657
-
Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas
-
Lee JH, Park SJ, Abraham SC, Seo JS, Nam JH, Choi C, Juhng SW, Rashid A, Hamilton SR, Wu TT. 2004. Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene 23:4646-4654.
-
(2004)
Oncogene
, vol.23
, pp. 4646-4654
-
-
Lee, J.H.1
Park, S.J.2
Abraham, S.C.3
Seo, J.S.4
Nam, J.H.5
Choi, C.6
Juhng, S.W.7
Rashid, A.8
Hamilton, S.R.9
Wu, T.T.10
-
102
-
-
0038118337
-
Effects of methylation on expression of TMSI/ASC in human breast cancer cells
-
Levine JJ, Stimson-Crider KM, Vertino PM. 2003. Effects of methylation on expression of TMSI/ASC in human breast cancer cells. Oncogene 22:3475-3488.
-
(2003)
Oncogene
, vol.22
, pp. 3475-3488
-
-
Levine, J.J.1
Stimson-Crider, K.M.2
Vertino, P.M.3
-
103
-
-
0033609371
-
Methylation and silencing of the Thrombospondin-1 promoter in human cancer
-
Li Q, Ahuja N, Burger PC, Issa JP. 1999. Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Oncogene 18:3284-3289.
-
(1999)
Oncogene
, vol.18
, pp. 3284-3289
-
-
Li, Q.1
Ahuja, N.2
Burger, P.C.3
Issa, J.P.4
-
104
-
-
0036171225
-
Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine
-
Liang G, Gonzales FA, Jones PA, Orntoft TF, Thykjaer T. 2002. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res 62:961-966.
-
(2002)
Cancer Res
, vol.62
, pp. 961-966
-
-
Liang, G.1
Gonzales, F.A.2
Jones, P.A.3
Orntoft, T.F.4
Thykjaer, T.5
-
105
-
-
33745320974
-
Targeting histone deacetylase in cancer therapy
-
Lin HY, Chen CS, Lin SP, Weng JR, Chen CS. 2006. Targeting histone deacetylase in cancer therapy. Med Res Rev 26:397-413.
-
(2006)
Med Res Rev
, vol.26
, pp. 397-413
-
-
Lin, H.Y.1
Chen, C.S.2
Lin, S.P.3
Weng, J.R.4
Chen, C.S.5
-
106
-
-
0038408486
-
Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion
-
Liu LT, Chang HC, Chiang LC, Hung WC. 2003. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Res 63:3069-3072.
-
(2003)
Cancer Res
, vol.63
, pp. 3069-3072
-
-
Liu, L.T.1
Chang, H.C.2
Chiang, L.C.3
Hung, W.C.4
-
107
-
-
33645950778
-
Histone deacetylase inhibitors: Multifunctional anticancer agents
-
Liu T, Kuljaca S, Tee A, Marshall GM. 2006. Histone deacetylase inhibitors: multifunctional anticancer agents. Cancer Treat Rev 32:157-165.
-
(2006)
Cancer Treat Rev
, vol.32
, pp. 157-165
-
-
Liu, T.1
Kuljaca, S.2
Tee, A.3
Marshall, G.M.4
-
108
-
-
20144383392
-
Functional epigenomics identifies genes frequently silenced in prostate cancer
-
Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. 2005. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65:4218-4227.
-
(2005)
Cancer Res
, vol.65
, pp. 4218-4227
-
-
Lodygin, D.1
Epanchintsev, A.2
Menssen, A.3
Diebold, J.4
Hermeking, H.5
-
109
-
-
16344391638
-
In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines
-
Loprevite M, Tiseo M, Grossi F, Scolaro T, Semino C, Pandolfi A, Favoni R, Ardizzoni A. 2005. In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines. Oncol Res 15:39-48.
-
(2005)
Oncol Res
, vol.15
, pp. 39-48
-
-
Loprevite, M.1
Tiseo, M.2
Grossi, F.3
Scolaro, T.4
Semino, C.5
Pandolfi, A.6
Favoni, R.7
Ardizzoni, A.8
-
110
-
-
1442330508
-
Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo
-
Luo J, Li M, Tang Y, Laszkowska M, Roeder RG, Gu W. 2004. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 101:2259-2264.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 2259-2264
-
-
Luo, J.1
Li, M.2
Tang, Y.3
Laszkowska, M.4
Roeder, R.G.5
Gu, W.6
-
111
-
-
33646709661
-
Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells
-
Luo W, Wang X, Kageshita T, Wakasugi S, Karpf AR, Ferrone S. 2006. Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells. Oncogene 25:2873-2884.
-
(2006)
Oncogene
, vol.25
, pp. 2873-2884
-
-
Luo, W.1
Wang, X.2
Kageshita, T.3
Wakasugi, S.4
Karpf, A.R.5
Ferrone, S.6
-
112
-
-
0034548836
-
Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells
-
Maeda T, Towatari M, Kosugi H, Saito H. 2000. Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells. Blood 96:3847-3856.
-
(2000)
Blood
, vol.96
, pp. 3847-3856
-
-
Maeda, T.1
Towatari, M.2
Kosugi, H.3
Saito, H.4
-
113
-
-
0034671618
-
-
Magner WJ, Kazim AL, Stewart C, Romano MA, Catalano G, Grande C, Keiser N, Santaniello F, Tomasi TB. 2000. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol 165:7017-7024.
-
Magner WJ, Kazim AL, Stewart C, Romano MA, Catalano G, Grande C, Keiser N, Santaniello F, Tomasi TB. 2000. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol 165:7017-7024.
-
-
-
-
114
-
-
0242539831
-
Epigenetic targets for immune intervention in human malignancies
-
Maio M, Coral S, Fratta E, Altomonte M, Sigalotti L. 2003. Epigenetic targets for immune intervention in human malignancies. Oncogene 22:6484-6488.
-
(2003)
Oncogene
, vol.22
, pp. 6484-6488
-
-
Maio, M.1
Coral, S.2
Fratta, E.3
Altomonte, M.4
Sigalotti, L.5
-
115
-
-
0029011539
-
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
-
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. 1995. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692.
-
(1995)
Nat Med
, vol.1
, pp. 686-692
-
-
Merlo, A.1
Herman, J.G.2
Mao, L.3
Lee, D.J.4
Gabrielson, E.5
Burger, P.C.6
Baylin, S.B.7
Sidransky, D.8
-
116
-
-
0026584248
-
Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: Induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma
-
Mittelman A, Chen ZJ, Yang H, Wong GY, Ferrone S. 1992. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci USA 89:466-470.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 466-470
-
-
Mittelman, A.1
Chen, Z.J.2
Yang, H.3
Wong, G.Y.4
Ferrone, S.5
-
117
-
-
25844465921
-
Epigenetic therapy of cancer with 5-aza-2′-deoxycytidine (decitabine)
-
Momparler RL. 2005. Epigenetic therapy of cancer with 5-aza-2′-deoxycytidine (decitabine). Semin Oncol 32:443-451.
-
(2005)
Semin Oncol
, vol.32
, pp. 443-451
-
-
Momparler, R.L.1
-
118
-
-
0030974771
-
Pilot phase I-II study on 5-aza-2′-deoxycytidine (Decitabine) in patients with metastatic lung cancer
-
Momparler RL, Bouffard DY, Momparler LF, Dionne J, Belanger K, Ayoub J. 1997. Pilot phase I-II study on 5-aza-2′-deoxycytidine (Decitabine) in patients with metastatic lung cancer. Anticancer Drugs 8:358-368.
-
(1997)
Anticancer Drugs
, vol.8
, pp. 358-368
-
-
Momparler, R.L.1
Bouffard, D.Y.2
Momparler, L.F.3
Dionne, J.4
Belanger, K.5
Ayoub, J.6
-
119
-
-
17444409344
-
Epigenetic reprogramming in mammals. Hum Mol Genet 14:R47-R58
-
Morgan HD, Santos F, Green K, Dean W, Reik W. 2005. Epigenetic reprogramming in mammals. Hum Mol Genet 14:R47-R58. Spec No 1:R47-R58.
-
(2005)
Spec No
, vol.1
-
-
Morgan, H.D.1
Santos, F.2
Green, K.3
Dean, W.4
Reik, W.5
-
120
-
-
33748360764
-
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci
-
Munshi A, Tanaka T, Hobbs ML, Tucker SL, Richon VM, Meyn RE. 2006. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol Cancer Ther 5:1967-1974.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 1967-1974
-
-
Munshi, A.1
Tanaka, T.2
Hobbs, M.L.3
Tucker, S.L.4
Richon, V.M.5
Meyn, R.E.6
-
121
-
-
0032468051
-
Hypomethylation of the metastasis- associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines
-
Nakamura N, Takenaga K. 1998. Hypomethylation of the metastasis- associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 16:471-479.
-
(1998)
Clin Exp Metastasis
, vol.16
, pp. 471-479
-
-
Nakamura, N.1
Takenaga, K.2
-
122
-
-
4344666663
-
Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells
-
Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M, Sakai T. 2004. Histone deacetylase inhibitors upregulate death receptor 5/TRAIL-R2 and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Oncogene 23:6261-6271.
-
(2004)
Oncogene
, vol.23
, pp. 6261-6271
-
-
Nakata, S.1
Yoshida, T.2
Horinaka, M.3
Shiraishi, T.4
Wakada, M.5
Sakai, T.6
-
123
-
-
1642289104
-
5-aza-2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis
-
Nam JS, Ino Y, Kanai Y, Sakamoto M, Hirohashi S. 2004. 5-aza-2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis. Clin Exp Metastasis 21:49-56.
-
(2004)
Clin Exp Metastasis
, vol.21
, pp. 49-56
-
-
Nam, J.S.1
Ino, Y.2
Kanai, Y.3
Sakamoto, M.4
Hirohashi, S.5
-
124
-
-
0034794672
-
DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas
-
Nie Y, Yang G, Song Y, Zhao X, So C, Liao J, Wang LD, Yang CS. 2001. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 22:1615-1623.
-
(2001)
Carcinogenesis
, vol.22
, pp. 1615-1623
-
-
Nie, Y.1
Yang, G.2
Song, Y.3
Zhao, X.4
So, C.5
Liao, J.6
Wang, L.D.7
Yang, C.S.8
-
125
-
-
18844397298
-
De novo DNA methytransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine
-
Oka M, Meacham AM, Hamazaki T, Rodic N, Chang LJ, Terada N. 2005. De novo DNA methytransferases Dnmt3a and Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine. Oncogene 24:3091-3099.
-
(2005)
Oncogene
, vol.24
, pp. 3091-3099
-
-
Oka, M.1
Meacham, A.M.2
Hamazaki, T.3
Rodic, N.4
Chang, L.J.5
Terada, N.6
-
126
-
-
0035890776
-
Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines
-
Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T. 2001. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines. Cancer Res 61:8331-8339.
-
(2001)
Cancer Res
, vol.61
, pp. 8331-8339
-
-
Osada, H.1
Tatematsu, Y.2
Masuda, A.3
Saito, T.4
Sugiyama, M.5
Yanagisawa, K.6
Takahashi, T.7
-
127
-
-
0037709969
-
Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo
-
Pakneshan P, Xing RH, Rabbani SA. 2003. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo. FASEB J 17:1081-1088.
-
(2003)
FASEB J
, vol.17
, pp. 1081-1088
-
-
Pakneshan, P.1
Xing, R.H.2
Rabbani, S.A.3
-
128
-
-
14844353574
-
Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors
-
Peart MJ, Smyth GK, van Laar RK, Bowtell DD, Richon VM, Marks PA, Holloway AJ, Johnstone RW. 2005. Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors. Proc Natl Acad Sci USA 102:3697-3702.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 3697-3702
-
-
Peart, M.J.1
Smyth, G.K.2
van Laar, R.K.3
Bowtell, D.D.4
Richon, V.M.5
Marks, P.A.6
Holloway, A.J.7
Johnstone, R.W.8
-
129
-
-
0021160287
-
5-Aza-2′-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias
-
Pinto A, Attadia V, Fusco A, Ferrara F, Spada OA, Di Fiore PP. 1984. 5-Aza-2′-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. Blood 64:922-929.
-
(1984)
Blood
, vol.64
, pp. 922-929
-
-
Pinto, A.1
Attadia, V.2
Fusco, A.3
Ferrara, F.4
Spada, O.A.5
Di Fiore, P.P.6
-
130
-
-
0034326784
-
Reversal of drug resistance in human tumor xenografts by 2′-deoxy-5-azacytidine- induced demethylation of the hMLH1 gene promoter
-
Plumb JA, Strathdee G, Sludden J, Kaye SB, Brown R. 2000. Reversal of drug resistance in human tumor xenografts by 2′-deoxy-5-azacytidine- induced demethylation of the hMLH1 gene promoter. Cancer Res 60:6039-6044.
-
(2000)
Cancer Res
, vol.60
, pp. 6039-6044
-
-
Plumb, J.A.1
Strathdee, G.2
Sludden, J.3
Kaye, S.B.4
Brown, R.5
-
131
-
-
22844437430
-
Activation of p53/p2IWafI/Cip1 pathway by 5-aza-2′-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells
-
Pulukuri SM, Rao JS. 2005. Activation of p53/p2IWafI/Cip1 pathway by 5-aza-2′-deoxycytidine inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein kinases in human prostate cancer cells. Int J Oncol 26:863-871.
-
(2005)
Int J Oncol
, vol.26
, pp. 863-871
-
-
Pulukuri, S.M.1
Rao, J.S.2
-
132
-
-
0032168678
-
CpG methylation, chromatin structure and gene silencing-a three-way connection
-
Razin A. 1998. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J 17:4905-4908.
-
(1998)
EMBO J
, vol.17
, pp. 4905-4908
-
-
Razin, A.1
-
133
-
-
0035234557
-
Genomic imprinting: Parental influence on the genome
-
Reik W, Walter J. 2001. Genomic imprinting: parental influence on the genome. Nat Rev Genet 2:21-32.
-
(2001)
Nat Rev Genet
, vol.2
, pp. 21-32
-
-
Reik, W.1
Walter, J.2
-
134
-
-
33747339752
-
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation
-
Reu FJ, Bae SI, Cherkassky L, Leaman DW, Lindner D, Beaulieu N, MacLeod AR, Borden EC. 2006a. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation. J Clin Oncol 24:3771-3779.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3771-3779
-
-
Reu, F.J.1
Bae, S.I.2
Cherkassky, L.3
Leaman, D.W.4
Lindner, D.5
Beaulieu, N.6
MacLeod, A.R.7
Borden, E.C.8
-
135
-
-
33645050917
-
Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons
-
Reu FJ, Leaman DW, Maitra RR, Bae SI, Cherkassky L, Fox MW, Rempinski DR, Beaulieu N, MacLeod AR, Borden EC. 2006b. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons. Cancer Res 66:2785-2793.
-
(2006)
Cancer Res
, vol.66
, pp. 2785-2793
-
-
Reu, F.J.1
Leaman, D.W.2
Maitra, R.R.3
Bae, S.I.4
Cherkassky, L.5
Fox, M.W.6
Rempinski, D.R.7
Beaulieu, N.8
MacLeod, A.R.9
Borden, E.C.10
-
136
-
-
0034730127
-
Histone deacetylase inhibitor selectively induces p2IWAFI expression and gene-associated histone acetylation
-
Richon VM, Sandhoff TW, Rifkind RA, Marks PA. 2000. Histone deacetylase inhibitor selectively induces p2IWAFI expression and gene-associated histone acetylation. Proc Natl Acad Sci USA 97:10014-10019.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 10014-10019
-
-
Richon, V.M.1
Sandhoff, T.W.2
Rifkind, R.A.3
Marks, P.A.4
-
137
-
-
0031771497
-
The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53
-
Robertson KD, Jones PA. 1998. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol 18:6457-6473.
-
(1998)
Mol Cell Biol
, vol.18
, pp. 6457-6473
-
-
Robertson, K.D.1
Jones, P.A.2
-
138
-
-
0036525616
-
5′ CpG island hypermethylation is associated with transcriptional silencing of the p21 (CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia
-
Roman-Gomez J, Castillejo JA, Jimenez A, Gonzalez MG, Moreno F, Rodriguez MC, Barrios M, Maldonado J, Torres A. 2002. 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21 (CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia. Blood 99:2291-2296.
-
(2002)
Blood
, vol.99
, pp. 2291-2296
-
-
Roman-Gomez, J.1
Castillejo, J.A.2
Jimenez, A.3
Gonzalez, M.G.4
Moreno, F.5
Rodriguez, M.C.6
Barrios, M.7
Maldonado, J.8
Torres, A.9
-
139
-
-
33646051586
-
Superiority of prolonged low-dose azanucleoside administration? Results of S-aza-2′-deoxycytidine retreatment in high-risk myelodysplasia patients
-
Ruter B, Wijermans PW, Lubbert M. 2006. Superiority of prolonged low-dose azanucleoside administration? Results of S-aza-2′-deoxycytidine retreatment in high-risk myelodysplasia patients. Cancer 106:1744-1750.
-
(2006)
Cancer
, vol.106
, pp. 1744-1750
-
-
Ruter, B.1
Wijermans, P.W.2
Lubbert, M.3
-
140
-
-
12344330351
-
Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines
-
Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP. 2005. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Exp Hematol 33:53-61.
-
(2005)
Exp Hematol
, vol.33
, pp. 53-61
-
-
Sakajiri, S.1
Kumagai, T.2
Kawamata, N.3
Saitoh, T.4
Said, J.W.5
Koeffler, H.P.6
-
141
-
-
21244449980
-
Evaluation of a 7-day continuous intravenous infusion of decitabine: Inhibition of promoter-specific and global genomic DNA methylation
-
Samlowski WE, Leachman SA, Wade M, Cassidy P, Porter-Gill P, Busby L, Wheeler R, Boucher K, Fitzpatrick F, Jones DA, Karpf AR. 2005. Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation. J Clin Oncol 23:3897-3905.
-
(2005)
J Clin Oncol
, vol.23
, pp. 3897-3905
-
-
Samlowski, W.E.1
Leachman, S.A.2
Wade, M.3
Cassidy, P.4
Porter-Gill, P.5
Busby, L.6
Wheeler, R.7
Boucher, K.8
Fitzpatrick, F.9
Jones, D.A.10
Karpf, A.R.11
-
142
-
-
0035799382
-
Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications
-
Santini V, Kantarjian HM, Issa JP. 2001. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134:573-586.
-
(2001)
Ann Intern Med
, vol.134
, pp. 573-586
-
-
Santini, V.1
Kantarjian, H.M.2
Issa, J.P.3
-
143
-
-
0035139039
-
Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer
-
Sasaki M, Dharia A, Oh BR, Tanaka Y, Fujimoto S, Dahiya R. 2001. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res 61:97-102.
-
(2001)
Cancer Res
, vol.61
, pp. 97-102
-
-
Sasaki, M.1
Dharia, A.2
Oh, B.R.3
Tanaka, Y.4
Fujimoto, S.5
Dahiya, R.6
-
144
-
-
0037453906
-
Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness
-
Sato N, Maehara N, Su GH, Goggins M. 2003. Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. J Natl Cancer Inst 95:327-330.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 327-330
-
-
Sato, N.1
Maehara, N.2
Su, G.H.3
Goggins, M.4
-
145
-
-
13444291198
-
Epigenetic inactivation of TFP1-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma
-
Sato N, Parker AR, Fukushima N, Miyagi Y, Iacobuzio-Donahue CA, Eshleman JR, Goggins M. 2005. Epigenetic inactivation of TFP1-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. Oncogene 24:850-858.
-
(2005)
Oncogene
, vol.24
, pp. 850-858
-
-
Sato, N.1
Parker, A.R.2
Fukushima, N.3
Miyagi, Y.4
Iacobuzio-Donahue, C.A.5
Eshleman, J.R.6
Goggins, M.7
-
146
-
-
10644234779
-
Epigenetic inactivation of class II trans activator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells
-
Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K. 2004. Epigenetic inactivation of class II trans activator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells. Oncogene 23:8876-8886.
-
(2004)
Oncogene
, vol.23
, pp. 8876-8886
-
-
Satoh, A.1
Toyota, M.2
Ikeda, H.3
Morimoto, Y.4
Akino, K.5
Mita, H.6
Suzuki, H.7
Sasaki, Y.8
Kanaseki, T.9
Takamura, Y.10
Soejima, H.11
Urano, T.12
Yanagihara, K.13
Endo, T.14
Hinoda, Y.15
Fujita, M.16
Hosokawa, M.17
Sato, N.18
Tokino, T.19
Imai, K.20
more..
-
147
-
-
2942591945
-
The cancer/testis genes: Review, standardization, and commentary
-
Scanlan MJ, Simpson AJ, Old LJ. 2004. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4:1.
-
(2004)
Cancer Immun
, vol.4
, pp. 1
-
-
Scanlan, M.J.1
Simpson, A.J.2
Old, L.J.3
-
148
-
-
14844313747
-
5-Aza-2′-deoxycytidine induces p2IWAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia
-
Schmelz K, Wagner M, Dorken B, Tamm I. 2005. 5-Aza-2′-deoxycytidine induces p2IWAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia. Int J Cancer 114:683-695.
-
(2005)
Int J Cancer
, vol.114
, pp. 683-695
-
-
Schmelz, K.1
Wagner, M.2
Dorken, B.3
Tamm, I.4
-
149
-
-
24744456138
-
Targeting the epigenome for the treatment and prevention of lung cancer
-
Schrump DS, Nguyen DM. 2005. Targeting the epigenome for the treatment and prevention of lung cancer. Semin Oncol 32:488-502.
-
(2005)
Semin Oncol
, vol.32
, pp. 488-502
-
-
Schrump, D.S.1
Nguyen, D.M.2
-
150
-
-
33750326078
-
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura
-
Schrump DS, Fischette MR, Nguyen DM, Zhao M, Li X, Kunst TF, Hancox A, Hong JA, Chen GA, Pishchik V, Figg WD, Murgo AJ, Steinberg SM. 2006. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura. Clin Cancer Res 12:5777-5785.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5777-5785
-
-
Schrump, D.S.1
Fischette, M.R.2
Nguyen, D.M.3
Zhao, M.4
Li, X.5
Kunst, T.F.6
Hancox, A.7
Hong, J.A.8
Chen, G.A.9
Pishchik, V.10
Figg, W.D.11
Murgo, A.J.12
Steinberg, S.M.13
-
151
-
-
33748967231
-
Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine
-
Segura-Pacheco B, Perez-Cardenas E, Taja-Chayeb L, Chavez-Bianco A, Revilla-Vazquez A, Itez-Bribiesca L, Duenas-Gonzalez A. 2006. Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine. J Transl Med 4:32.
-
(2006)
J Transl Med
, vol.4
, pp. 32
-
-
Segura-Pacheco, B.1
Perez-Cardenas, E.2
Taja-Chayeb, L.3
Chavez-Bianco, A.4
Revilla-Vazquez, A.5
Itez-Bribiesca, L.6
Duenas-Gonzalez, A.7
-
152
-
-
0035886022
-
Reexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′- deoxycytidine treatment
-
Serrano A, Tanzarella S, Lionello I, Mendez R, Traversari C, Ruiz-Cabello F, Garrido F. 2001. Reexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′- deoxycytidine treatment. Int J Cancer 94: 243-251.
-
(2001)
Int J Cancer
, vol.94
, pp. 243-251
-
-
Serrano, A.1
Tanzarella, S.2
Lionello, I.3
Mendez, R.4
Traversari, C.5
Ruiz-Cabello, F.6
Garrido, F.7
-
153
-
-
33745685866
-
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: Tamoxifen-bound reactivated ER recruits distinctive corepressor complexes
-
Sharma D, Saxena NK, Davidson NE, Vertino PM. 2006. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. Cancer Res 66:6370-6378.
-
(2006)
Cancer Res
, vol.66
, pp. 6370-6378
-
-
Sharma, D.1
Saxena, N.K.2
Davidson, N.E.3
Vertino, P.M.4
-
154
-
-
0034650338
-
Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells
-
Shin JY, Kim HS, Park J, Park JB, Lee JY. 2000. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res 60:262-265.
-
(2000)
Cancer Res
, vol.60
, pp. 262-265
-
-
Shin, J.Y.1
Kim, H.S.2
Park, J.3
Park, J.B.4
Lee, J.Y.5
-
155
-
-
33749483782
-
Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo
-
Shukeir N, Pakneshan P, Chen G, Szyf M, Rabbani SA. 2006. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. Cancer Res 66:9202-9210.
-
(2006)
Cancer Res
, vol.66
, pp. 9202-9210
-
-
Shukeir, N.1
Pakneshan, P.2
Chen, G.3
Szyf, M.4
Rabbani, S.A.5
-
156
-
-
31544439666
-
Discovery of two novel, small-molecule inhibitors of DNA methylation
-
Siedlecki P, Boy RG, Musch T, Brueckner B, Suhai S, Lyko F, Zielenkiewicz P. 2006. Discovery of two novel, small-molecule inhibitors of DNA methylation. J Med Chem 49:678-683.
-
(2006)
J Med Chem
, vol.49
, pp. 678-683
-
-
Siedlecki, P.1
Boy, R.G.2
Musch, T.3
Brueckner, B.4
Suhai, S.5
Lyko, F.6
Zielenkiewicz, P.7
-
157
-
-
0036139334
-
Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma
-
Sigalotti L, Coral S, Nardi G, Spessotto A, Cortini E, Cattarossi I, Colizzi F, Altomonte M, Maio M. 2002. Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma. J Immunother 25:16-26.
-
(2002)
J Immunother
, vol.25
, pp. 16-26
-
-
Sigalotti, L.1
Coral, S.2
Nardi, G.3
Spessotto, A.4
Cortini, E.5
Cattarossi, I.6
Colizzi, F.7
Altomonte, M.8
Maio, M.9
-
158
-
-
0038142344
-
5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies: A multimechanism therapeutic approach?
-
Sigalotti L, Altomonte M, Colizzi F, Degan M, Rupolo M, Zagonel V, Pinto A, Gattei V, Maio M. 2003. 5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach? Blood 101:4644-4646.
-
(2003)
Blood
, vol.101
, pp. 4644-4646
-
-
Sigalotti, L.1
Altomonte, M.2
Colizzi, F.3
Degan, M.4
Rupolo, M.5
Zagonel, V.6
Pinto, A.7
Gattei, V.8
Maio, M.9
-
159
-
-
10844289762
-
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is rnethylation-regulated and functionally reverted by 5-aza-2′- deoxycytidine
-
Sigalotti L, Fratta E, Coral S, Tanzarella S, Danielli R, Colizzi F, Fonsatti E, Traversari C, Altomonte M, Maio M. 2004. Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is rnethylation-regulated and functionally reverted by 5-aza-2′- deoxycytidine. Cancer Res 64:9167-9171.
-
(2004)
Cancer Res
, vol.64
, pp. 9167-9171
-
-
Sigalotti, L.1
Fratta, E.2
Coral, S.3
Tanzarella, S.4
Danielli, R.5
Colizzi, F.6
Fonsatti, E.7
Traversari, C.8
Altomonte, M.9
Maio, M.10
-
160
-
-
25844530904
-
Epigenetic modulation of solid tumors as a novel approach for cancer immunotherapy
-
Sigalotti L, Coral S, Fratta E, Lamaj E, Danielli R, Di Giacomo AM, Altomonte M, Maio M. 2005. Epigenetic modulation of solid tumors as a novel approach for cancer immunotherapy. Semin Oncol 32:473-478.
-
(2005)
Semin Oncol
, vol.32
, pp. 473-478
-
-
Sigalotti, L.1
Coral, S.2
Fratta, E.3
Lamaj, E.4
Danielli, R.5
Di Giacomo, A.M.6
Altomonte, M.7
Maio, M.8
-
161
-
-
0035874991
-
Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells
-
Singal R, van Wert J, Bashambu M. 2001. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Cancer Res 61:4820-4826.
-
(2001)
Cancer Res
, vol.61
, pp. 4820-4826
-
-
Singal, R.1
van Wert, J.2
Bashambu, M.3
-
162
-
-
0036558155
-
Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer
-
Sirchia SM, Ren M, Pili R, Sironi E, Somenzi G, Ghidoni R, Toma S, Nicolo G, Sacchi N. 2002. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 62:2455-2461.
-
(2002)
Cancer Res
, vol.62
, pp. 2455-2461
-
-
Sirchia, S.M.1
Ren, M.2
Pili, R.3
Sironi, E.4
Somenzi, G.5
Ghidoni, R.6
Toma, S.7
Nicolo, G.8
Sacchi, N.9
-
163
-
-
0035843169
-
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
-
Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW. 2001. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409:207-211.
-
(2001)
Nature
, vol.409
, pp. 207-211
-
-
Soengas, M.S.1
Capodieci, P.2
Polsky, D.3
Mora, J.4
Esteller, M.5
Opitz-Araya, X.6
McCombie, R.7
Herman, J.G.8
Gerald, W.L.9
Lazebnik, Y.A.10
Cordon-Cardo, C.11
Lowe, S.W.12
-
164
-
-
20144388727
-
Sequential 5-Aza 2′-deoxycytidine/ depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells
-
Sterner FA. Hong JA, Fischette MR, Beer DG, Guo ZS, Chen GA, Weiser TS, Kassis ES, Nguyen DM, Lee S, Trepel JB, Schrump DS. 2005. Sequential 5-Aza 2′-deoxycytidine/ depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells. Oncogene 24:2386-2397.
-
(2005)
Oncogene
, vol.24
, pp. 2386-2397
-
-
Sterner, F.A.1
Hong, J.A.2
Fischette, M.R.3
Beer, D.G.4
Guo, Z.S.5
Chen, G.A.6
Weiser, T.S.7
Kassis, E.S.8
Nguyen, D.M.9
Lee, S.10
Trepel, J.B.11
Schrump, D.S.12
-
165
-
-
0030925099
-
Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors
-
Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ. 1997. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57:2229-2237.
-
(1997)
Cancer Res
, vol.57
, pp. 2229-2237
-
-
Stirzaker, C.1
Millar, D.S.2
Paul, C.L.3
Warnecke, P.M.4
Harrison, J.5
Vincent, P.C.6
Frommer, M.7
Clark, S.J.8
-
166
-
-
0034610814
-
The language of covalent histone modifications
-
Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 403: 41-45.
-
(2000)
Nature
, vol.403
, pp. 41-45
-
-
Strahl, B.D.1
Allis, C.D.2
-
167
-
-
33645086120
-
Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines
-
Stresemann C, Brueckner B, Musch T, Stopper H, Lyko F. 2006. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res 66:2794-2800.
-
(2006)
Cancer Res
, vol.66
, pp. 2794-2800
-
-
Stresemann, C.1
Brueckner, B.2
Musch, T.3
Stopper, H.4
Lyko, F.5
-
168
-
-
16344380408
-
Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228)
-
Sutheesophon K, Nishimura N, Kobayashi Y, Furukawa Y, Kawano M, Itoh K, Kano Y, Ishii H, Furukawa Y. 2005. Involvement of the tumor necrosis factor (TNF)/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228). J Cell Physiol 203:387-397.
-
(2005)
J Cell Physiol
, vol.203
, pp. 387-397
-
-
Sutheesophon, K.1
Nishimura, N.2
Kobayashi, Y.3
Furukawa, Y.4
Kawano, M.5
Itoh, K.6
Kano, Y.7
Ishii, H.8
Furukawa, Y.9
-
169
-
-
0036613250
-
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
-
Suzuki H, Gabrielson E, Chen W, Anbazhagan R, Van EM, Weijenberg MP, Herman JG, Baylin SB. 2002. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31:141-149.
-
(2002)
Nat Genet
, vol.31
, pp. 141-149
-
-
Suzuki, H.1
Gabrielson, E.2
Chen, W.3
Anbazhagan, R.4
Van, E.M.5
Weijenberg, M.P.6
Herman, J.G.7
Baylin, S.B.8
-
170
-
-
12144291274
-
-
Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van EM, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB. 2004. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36:417-422.
-
Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van EM, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB. 2004. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36:417-422.
-
-
-
-
171
-
-
29144500326
-
Decitabine activates specific caspases downstream of p73 in myeloid leukemia
-
Tamm J, Wagner M, Schmelz K. 2005. Decitabine activates specific caspases downstream of p73 in myeloid leukemia. Ann Hematol 84 Suppl 13:47-53.
-
(2005)
Ann Hematol
, vol.84
, Issue.SUPPL. 13
, pp. 47-53
-
-
Tamm, J.1
Wagner, M.2
Schmelz, K.3
-
172
-
-
0032145266
-
Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas
-
Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K. 1998. Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 58:3429-3434.
-
(1998)
Cancer Res
, vol.58
, pp. 3429-3434
-
-
Tanaka, H.1
Shimada, Y.2
Harada, H.3
Shinoda, M.4
Hatooka, S.5
Imamura, M.6
Ishizaki, K.7
-
173
-
-
12744280832
-
Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells
-
Tang X, Wu W, Sun SY, Wistuba II, Hong WK, Mao L. 2004. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells. Mol Cancer Res 2:685-691.
-
(2004)
Mol Cancer Res
, vol.2
, pp. 685-691
-
-
Tang, X.1
Wu, W.2
Sun, S.Y.3
Wistuba, I.I.4
Hong, W.K.5
Mao, L.6
-
174
-
-
0034066405
-
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
-
Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ. 2000. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6:529-535.
-
(2000)
Nat Med
, vol.6
, pp. 529-535
-
-
Teitz, T.1
Wei, T.2
Valentine, M.B.3
Vanin, E.F.4
Grenet, J.5
Valentine, V.A.6
Behm, F.G.7
Look, A.T.8
Lahti, J.M.9
Kidd, V.J.10
-
175
-
-
9144266953
-
Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors
-
Terui T, Murakami K, Takimoto R, Takahashi M, Takada K, Murakami T, Minami S, Matsunaga T, Takayama T, Kato J, Niitsu Y. 2003. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. Cancer Res 63:8948-8954.
-
(2003)
Cancer Res
, vol.63
, pp. 8948-8954
-
-
Terui, T.1
Murakami, K.2
Takimoto, R.3
Takahashi, M.4
Takada, K.5
Murakami, T.6
Minami, S.7
Matsunaga, T.8
Takayama, T.9
Kato, J.10
Niitsu, Y.11
-
176
-
-
0029774145
-
Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor
-
Thompson JS, Reese KJ, DeBaun MR, Perlman EJ, Feinberg AP. 1996. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor. Cancer Res 56:5723-5727.
-
(1996)
Cancer Res
, vol.56
, pp. 5723-5727
-
-
Thompson, J.S.1
Reese, K.J.2
DeBaun, M.R.3
Perlman, E.J.4
Feinberg, A.P.5
-
177
-
-
26944458941
-
-
Tosi GM, Trimarchi C, Macaluso M. La 5D. Ciccodicola A, Lazzi S, Massaro-Giordano M, Caporossi A, Giordano A, Cinti C. 2005. Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach. Oncogene 24:5827-5836.
-
Tosi GM, Trimarchi C, Macaluso M. La 5D. Ciccodicola A, Lazzi S, Massaro-Giordano M, Caporossi A, Giordano A, Cinti C. 2005. Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach. Oncogene 24:5827-5836.
-
-
-
-
178
-
-
0035360824
-
Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas
-
Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF. 2001. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res 61:4556-4560.
-
(2001)
Cancer Res
, vol.61
, pp. 4556-4560
-
-
Toyooka, K.O.1
Toyooka, S.2
Virmani, A.K.3
Sathyanarayana, U.G.4
Euhus, D.M.5
Gilcrease, M.6
Minna, J.D.7
Gazdar, A.F.8
-
179
-
-
6344222799
-
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor
-
Vannini A, Volpari C, Filocamo G, Casavola EC, Brunetti M, Renzoni D, Chakravarty P, Paolini C, De FR, Gallinari P, Steinkuhler C, Di MS, 2004. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc Natl Acad Sci USA 101:15064-15069.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 15064-15069
-
-
Vannini, A.1
Volpari, C.2
Filocamo, G.3
Casavola, E.C.4
Brunetti, M.5
Renzoni, D.6
Chakravarty, P.7
Paolini, C.8
De, F.R.9
Gallinari, P.10
Steinkuhler, C.11
Di, M.S.12
-
180
-
-
0041939756
-
Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells
-
Villar-Garea A, Fraga MF, Espada J, Esteller M. 2003. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res 63:4984-4989.
-
(2003)
Cancer Res
, vol.63
, pp. 4984-4989
-
-
Villar-Garea, A.1
Fraga, M.F.2
Espada, J.3
Esteller, M.4
-
181
-
-
17844395749
-
Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer
-
Wang W, Huper G, Guo Y, Murphy SK, Olson JAJr, Marks JR. 2005. Analysis of methylation-sensitive transcriptome identifies GADD45a as a frequently methylated gene in breast cancer. Oncogene 24:2705-2714.
-
(2005)
Oncogene
, vol.24
, pp. 2705-2714
-
-
Wang, W.1
Huper, G.2
Guo, Y.3
Murphy, S.K.4
JAJr, O.5
Marks, J.R.6
-
182
-
-
0028328854
-
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine
-
Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg SA. 1994. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res 54:1766-1771.
-
(1994)
Cancer Res
, vol.54
, pp. 1766-1771
-
-
Weber, J.1
Salgaller, M.2
Samid, D.3
Johnson, B.4
Herlyn, M.5
Lassam, N.6
Treisman, J.7
Rosenberg, S.A.8
-
183
-
-
23044514626
-
Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells
-
Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D. 2005. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37:853-862.
-
(2005)
Nat Genet
, vol.37
, pp. 853-862
-
-
Weber, M.1
Davies, J.J.2
Wittig, D.3
Oakeley, E.J.4
Haase, M.5
Lam, W.L.6
Schubeler, D.7
-
184
-
-
28244460828
-
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy
-
Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L, Xu J, Fackenthal J, Tretiakova M, Das S, Olopade OI. 2005. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 65:10692-10699.
-
(2005)
Cancer Res
, vol.65
, pp. 10692-10699
-
-
Wei, M.1
Grushko, T.A.2
Dignam, J.3
Hagos, F.4
Nanda, R.5
Sveen, L.6
Xu, J.7
Fackenthal, J.8
Tretiakova, M.9
Das, S.10
Olopade, O.I.11
-
185
-
-
0035126974
-
Sequential 5-aza-2′-deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1
-
Weiser TS, Guo ZS, Ohnmacht GA, Parkhurst ML, Tong-On P, Marincola FM, Fischette MR, Yu X, Chen GA, Hong JA, Stewart JH, Nguyen DM, Rosenberg SA, Schrump DS. 2001a. Sequential 5-aza-2′-deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1. J Immunother 24:151-161.
-
(2001)
J Immunother
, vol.24
, pp. 151-161
-
-
Weiser, T.S.1
Guo, Z.S.2
Ohnmacht, G.A.3
Parkhurst, M.L.4
Tong-On, P.5
Marincola, F.M.6
Fischette, M.R.7
Yu, X.8
Chen, G.A.9
Hong, J.A.10
Stewart, J.H.11
Nguyen, D.M.12
Rosenberg, S.A.13
Schrump, D.S.14
-
186
-
-
0035132573
-
Induction of MAGE-3 expression in lung and esophageal cancer cells
-
Weiser TS, Ohnmacht GA, Guo ZS, Fischette MR, Chen GA, Hong JA, Nguyen DM, Schrump DS. 2001b. Induction of MAGE-3 expression in lung and esophageal cancer cells. Ann Thorac Surg 71:295-301.
-
(2001)
Ann Thorac Surg
, vol.71
, pp. 295-301
-
-
Weiser, T.S.1
Ohnmacht, G.A.2
Guo, Z.S.3
Fischette, M.R.4
Chen, G.A.5
Hong, J.A.6
Nguyen, D.M.7
Schrump, D.S.8
-
187
-
-
0037068360
-
DNA methylation and breast carcinogenesis
-
Widschwendter M, Jones PA. 2002. DNA methylation and breast carcinogenesis. Oncogene 21:5462-5482.
-
(2002)
Oncogene
, vol.21
, pp. 5462-5482
-
-
Widschwendter, M.1
Jones, P.A.2
-
188
-
-
3042822370
-
DNA hypomethylation and ovarian cancer biology
-
Widschwendter M, Jiang G, Woods C, Muller HM, Fiegl H, Goebel G, Marth C, Muller-Holzner E, Zeimet AG, Laird PW, Ehrlich M. 2004. DNA hypomethylation and ovarian cancer biology. Cancer Res 64:4472-4480.
-
(2004)
Cancer Res
, vol.64
, pp. 4472-4480
-
-
Widschwendter, M.1
Jiang, G.2
Woods, C.3
Muller, H.M.4
Fiegl, H.5
Goebel, G.6
Marth, C.7
Muller-Holzner, E.8
Zeimet, A.G.9
Laird, P.W.10
Ehrlich, M.11
-
189
-
-
17444452612
-
Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients
-
Wijermans P, Lubbert M, Verhoef G, Bosly A, Ravoet C, Andre M, Ferrant A. 2000. Low-dose 5-aza-2′-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol 18:956-962.
-
(2000)
J Clin Oncol
, vol.18
, pp. 956-962
-
-
Wijermans, P.1
Lubbert, M.2
Verhoef, G.3
Bosly, A.4
Ravoet, C.5
Andre, M.6
Ferrant, A.7
-
190
-
-
33744829728
-
Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells
-
Wischnewski F, Pantel K, Schwarzenbach H. 2006. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol Cancer Res 4:339-349.
-
(2006)
Mol Cancer Res
, vol.4
, pp. 339-349
-
-
Wischnewski, F.1
Pantel, K.2
Schwarzenbach, H.3
-
191
-
-
0032940478
-
Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: Role of DNA methylation
-
Xing RH, Rabbani SA. 1999. Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: role of DNA methylation. Int J Cancer 81:443-450.
-
(1999)
Int J Cancer
, vol.81
, pp. 443-450
-
-
Xing, R.H.1
Rabbani, S.A.2
-
192
-
-
0035477320
-
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells
-
Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE. 2001. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 61:7025-7029.
-
(2001)
Cancer Res
, vol.61
, pp. 7025-7029
-
-
Yang, X.1
Phillips, D.L.2
Ferguson, A.T.3
Nelson, W.G.4
Herman, J.G.5
Davidson, N.E.6
-
193
-
-
33744918070
-
DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia
-
Yang AS, Doshi KD, Choi SW, Mason JB, Mannari RK, Gharybian V, Luna R, Rashid A, Shen L, Estecio MR, Kantarjian HM, Garcia-Manero G, Issa JP. 2006. DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia. Cancer Res 66:5495-5503.
-
(2006)
Cancer Res
, vol.66
, pp. 5495-5503
-
-
Yang, A.S.1
Doshi, K.D.2
Choi, S.W.3
Mason, J.B.4
Mannari, R.K.5
Gharybian, V.6
Luna, R.7
Rashid, A.8
Shen, L.9
Estecio, M.R.10
Kantarjian, H.M.11
Garcia-Manero, G.12
Issa, J.P.13
-
194
-
-
0030840954
-
Cytosine methylation and the ecology of intragenomic parasites
-
Yoder JA, Walsh CP, Bestor TH. 1997. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13:335-340.
-
(1997)
Trends Genet
, vol.13
, pp. 335-340
-
-
Yoder, J.A.1
Walsh, C.P.2
Bestor, T.H.3
-
195
-
-
0031000513
-
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B
-
Yogelzang NJ, Herndon JE, Cirrincione C, Harmon DC, Antman KH, Corson JM, Suzuki Y, Citron ML, Green MR. 1997. Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group B. Cancer 79:2237-2242.
-
(1997)
Cancer
, vol.79
, pp. 2237-2242
-
-
Yogelzang, N.J.1
Herndon, J.E.2
Cirrincione, C.3
Harmon, D.C.4
Antman, K.H.5
Corson, J.M.6
Suzuki, Y.7
Citron, M.L.8
Green, M.R.9
-
196
-
-
33644856123
-
Epigenetic therapy of cancer: Past, present and future
-
S
-
Yoo CB, Jones PA. 2006. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov S:37-50.
-
(2006)
Nat Rev Drug Discov
, pp. 37-50
-
-
Yoo, C.B.1
Jones, P.A.2
-
197
-
-
1942506634
-
Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers
-
Youssef EM, Chen XQ, Higuchi E, Kondo Y, Garcia-Manero G, Lotan R, Issa JP. 2004a. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers. Cancer Res 64:2411-2417.
-
(2004)
Cancer Res
, vol.64
, pp. 2411-2417
-
-
Youssef, E.M.1
Chen, X.Q.2
Higuchi, E.3
Kondo, Y.4
Garcia-Manero, G.5
Lotan, R.6
Issa, J.P.7
-
198
-
-
12144289388
-
Hypermethylation of the retinoic acid receptor-beta(2)gene in head and neck carcinogenesis
-
Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, Hassan K, Feng L, Lee JJ, Lippman SM, Hong WK, Lotan R. 2004b. Hypermethylation of the retinoic acid receptor-beta(2)gene in head and neck carcinogenesis. Clin Cancer Res 10:1733-1742.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 1733-1742
-
-
Youssef, E.M.1
Lotan, D.2
Issa, J.P.3
Wakasa, K.4
Fan, Y.H.5
Mao, L.6
Hassan, K.7
Feng, L.8
Lee, J.J.9
Lippman, S.M.10
Hong, W.K.11
Lotan, R.12
-
199
-
-
0041672342
-
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers
-
Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RCJr, Yu Y. 2003. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 63:4174-4180.
-
(2003)
Cancer Res
, vol.63
, pp. 4174-4180
-
-
Yuan, J.1
Luo, R.Z.2
Fujii, S.3
Wang, L.4
Hu, W.5
Andreeff, M.6
Pan, Y.7
Kadota, M.8
Oshimura, M.9
Sahin, A.A.10
Issa, J.P.11
Bast RCJr, Y.Y.12
-
201
-
-
0033809993
-
Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter
-
Zhang Q, Raghunath PN, Vonderheid E, Odum N, Wasik MA. 2000. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter. Am J Pathol 157:1137-1146.
-
(2000)
Am J Pathol
, vol.157
, pp. 1137-1146
-
-
Zhang, Q.1
Raghunath, P.N.2
Vonderheid, E.3
Odum, N.4
Wasik, M.A.5
-
202
-
-
2342564962
-
Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl) aminomethyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells
-
Zhang Y, Adachi M, Zhao X, Kawamura R, Imai K. 2004. Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl) aminomethyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells. Int J Cancer 110:301-308.
-
(2004)
Int J Cancer
, vol.110
, pp. 301-308
-
-
Zhang, Y.1
Adachi, M.2
Zhao, X.3
Kawamura, R.4
Imai, K.5
-
203
-
-
33645230001
-
Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21 (Waf1/Cip1)
-
Zhao Y, Lu S, Wu L, Chai G, Wang H, Chen Y, Sun J, Yu Y, Zhou W, Zheng Q, Wu M, Otterson GA, Zhu WG. 2006. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21 (Waf1/Cip1). Mol Cell Biol 26:2782-2790.
-
(2006)
Mol Cell Biol
, vol.26
, pp. 2782-2790
-
-
Zhao, Y.1
Lu, S.2
Wu, L.3
Chai, G.4
Wang, H.5
Chen, Y.6
Sun, J.7
Yu, Y.8
Zhou, W.9
Zheng, Q.10
Wu, M.11
Otterson, G.A.12
Zhu, W.G.13
-
204
-
-
0036965821
-
Zebularine: A novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases
-
Zhou L, Cheng X, Connolly BA, Dickman MJ, Hurd PJ, Hornby DP. 2002. Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol 321:591-599.
-
(2002)
J Mol Biol
, vol.321
, pp. 591-599
-
-
Zhou, L.1
Cheng, X.2
Connolly, B.A.3
Dickman, M.J.4
Hurd, P.J.5
Hornby, D.P.6
-
205
-
-
0035866353
-
DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors
-
Zhu WG, Lakshmanan RR, Beal MD, Otterson GA. 2001. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res 61:1327-1333.
-
(2001)
Cancer Res
, vol.61
, pp. 1327-1333
-
-
Zhu, W.G.1
Lakshmanan, R.R.2
Beal, M.D.3
Otterson, G.A.4
-
206
-
-
2442622595
-
5-aza-2′-deoxycytidine activates the p53/p2IWafI/Cip1 pathway to inhibit cell proliferation
-
Zhu WG, Hileman T, Ke Y, Wang P, Lu S, Duan W, Dai Z, Tong T, Villalona-Calero MA, Plass C, Otterson GA. 2004. 5-aza-2′-deoxycytidine activates the p53/p2IWafI/Cip1 pathway to inhibit cell proliferation. J Biol Chem 279:15161-15166.
-
(2004)
J Biol Chem
, vol.279
, pp. 15161-15166
-
-
Zhu, W.G.1
Hileman, T.2
Ke, Y.3
Wang, P.4
Lu, S.5
Duan, W.6
Dai, Z.7
Tong, T.8
Villalona-Calero, M.A.9
Plass, C.10
Otterson, G.A.11
|